chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Patient received vaccine Thursday afternoon at 12:30PM. By 5:00PM, patient stated he felt very tired and started having flu-like symptoms including headache, body aches, and overall malaise. Patient went to bed at 8:00PM because he was so tired.  Friday morning, the patient woke up at 7:30AM and had lost about 50% of his hearing in his RIGHT ear (vaccine in left arm). He said he felt like he was talking into a barrel, and he couldn't really hear high-pitched noises - low-pitched noises were more audible, but still muffled. He said he did not feel congested or stuffy at all, and it was only his right ear that was bothering him. He regularly cleans his ears, but did not clean them Thursday or Friday. He does not think he has wax build-up in the ear. Patient also stated that a close friend of his also reported hearing loss after receiving the shot, and that patient was currently seeking medical care for the hearing loss (that event did not occur here, but patient states the incident was reported by his physician). After discussion with the patient, we agreed that it could be the body's response to the vaccine and he might have some congestion/stuffiness/fluid that may be affecting the ear.  Patient is going to try a couple days of Claritin 10mg, one tablet daily, to see if it clears up until he can discuss with his doctor on Monday. Outcome is still pending. Patient was advised to notify us or his physician if symptoms worsen/
Chest tightness/pain, acid reflux, gas, throat discomfort, fever, injection site soreness, headache, fatigue, extreme nausea, and body aches.
AFTER SOME DAYS I STARTED GETTING PAIN IN MY CALF IN BOTH LEGS. THE PAIN GOT WORSE OVER THE LAST WEEKS, HURTING ALL MY JOINTS. I SAW THREE DIFFERNT Dr. A GENERAL PHYSICIAN, A PEDIATRICS AND A HEART A LEG SPECIALIST. ALL COULD NOT HELP. MY VEINS ARE COMPLETELY OPEN. HE FELT IT CAME FROM THE TETANUS INJECTION. I LOOKED UP TETANUS ON THE INTERNET AND FOUND THAT I HAVE SIMILAR SYMPTONS.
Initial report received from a consumer through social media site on 11 OCTOBER 2013.  A patient had received a dose of FLUZONE (lot number, dose number, route and anatomical site of administration were not reported) on an unspecified date.  On an unspecified date, the patient had developed experienced slightly sore in arm. Laboratory investigation was and corrective treatments were not reported. At the time of this report, the patient had not recovered from events. Documents held by sender: None.
Received vaccine on Friday.  Had side effects on Sat: Headache, vomiting, chills, low grade fever for a short time, aches and tiredness. (Had same side effects during first vaccination and received first vaccination in left arm 4/30/2021-same vaccination location). However, second dose produced round red circle around vaccination injection site.  It has been 36 hours and the injection site is warm to touch and itches.
Vaccines were given AM 6/18/03-per grandmother by 6PM 6/18/03 fever up to 104.0. >3 hours inconsolable crying/not drinking. Had OV 6/19, no other symptoms illness.
redness w/hardened lump 6cm x 2cm lt arm lasted 3 days;
The day after I got my vaccine I fainted which is not normal for me. I had a headache and nausea when I woke up but that is normal. I had gone to the kitchen to get a medication for my head. I felt that I was doing down so I leaned on the kitchen counter and the next thing I remember I was on the kitchen floor. My leg hurt and I had a huge bruise on my forehead. I was confused when I woke up and was not sure where I was I had to crawl to my hallway to get up off the floor. I felt okay and just recovered throughout the day. The next day I had an episode of nausea and headache again and an episode of light headedness but did not pass out. The follow day in the afternoon I was having this again and just did not feel right so I ended up in the hospital in the ER and they admitted me for observation.
dose Pfizer lot number EW0178 on 6/5/21  2nd dose Pfizer lot number EW0185 on 6/26/21  3rd dose Pfizer lot number lot manufacturing number 330368D on 1/8/22  Father gave verbal consent for vaccination.  States no prior adverse reactions to vaccines  14:45 Patient while sitting in chair stated she felt dizzy and was diaphoretic patient was helped to the floor and legs were elevated. Blood pressure 98/52 pulse 55 pulse OX 98 percent   14:47 BP 99/62 pulse 60 pulse ox 99 percent patient states starting to feel much better color more pink   no diaphoresis noted   14:50 BP 92/65  pulse 73 pulse ox 100 percent  color good. Sitting up states feeling much better   Alert oriented x3. 14:55 BP 90/68 pulse 91 pulse ox 96 percent. Patient and her parents will be in observation area for 20 mins
This spontaneous report as received from a registered nurse refers to 2 separate patients of unknown demographics. On 25-NOV-2013 the 2 separate patients were vaccinated with MMR II, dose 0.5 ml, subcutaneously from lot J006136 and expiry date 24-MAY-2015. No adverse effect was reported. The nurse reported that 2 doses of MMR that were exposed to 17 degrees Centigrade (also reported as out of temperature range) for 8.5 hours. Additional information has been requested.
missed the second dose; dizziness; This is a spontaneous report from a contactable consumer (patient) or other non HCP.   A 65-years-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/lot number: unknown and Expire Date: unknown) (age at the time of vaccination: 65-years-old), via unspecified route of administration on 26May2021 as single dose for Covid-19 immunisation. The patient medical history and concomitant medications were not reported. The patient had the first dose on 26May2021 and the second dose was due today at 11:30 but he experienced dizziness and missed it on an unspecified date. He wanted recommendations on what to do about it. He clarified the medication as Pfizer Covid 19. Patient stated that he experienced condition of dizziness. He wanted to know where to get to the dose that he missed today.   Information regarding the batch/lot number has been requested.  Follow-up (01Jul2021): This follow-up is being submitted to notify that the lot/batch number is not available despite the follow-up attempts made. Follow-up attempts have been completed and no further information is expected.
HISTORY OF PRESENT ILLNESS:  This patient is a gravida 4, para 2-0-1-2 female with an EDC of 06/30/2022 by LMP equal to ultrasound at 6 weeks and 3 days.  She is currently at 40 weeks and 2 days today.  She presents today for a spontaneous onset of labor.  She had been found to be 3 cm at the office on Wednesday.  She now comes in with regular pattern of contractions.  Her history has been complicated by recent COVID virus positive testing.  She also has had positive group B strep.
This spontaneous report as received from a Medical Assistant refers to a 14 years old female patient. The patient was vaccinated with dose 1 and dose 2 of GARDASIL on 14-MAR-2012 and 22-SEP-2012, respectively (dose, route, site of administration and lot # not reported). No adverse effects reported. Additional information is not expected.
CHRONIC HYPERCAPNIC RESPIRATORY FAILURE ACUTE ON CHRONIC HYPOXEMIC RESPIRATORY FAILURE ACUTE ON CHRONIC HYPERCAPNIC RESPIRATORY FAILURE HYPOXIA
Developed like a blood clot, black and blue in the arm; Developed like a blood clot, black and blue in the arm; This is a spontaneous report from a non-contactable consumer (patient). A patient of unspecified age and gender received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number and Expiration Date were not reported), via an unspecified route of administration, on an unspecified date, at a single dose, for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient previously took the first dose of BNT162B2 for COVID-19 immunization. The patient was calling about the side effects of Pfizer COVID-19 vaccine and was wondering. The patient got the first and second vaccine of Pfizer for COVID-19. After the second dose of vaccine on an unspecified date, the patient developed like a blood clot, black and blue in the arm. The patient wanted to ask if this is a rare side effects or common. The outcome of the events was unknown.  No follow-up attempts are possible; information about batch number cannot be obtained. No further information is expected.
He started with mild cold like symptoms but then it progressed to severe flu like symptoms.  Headaches,  sinus issues,  body hurting everywhere. Swollen face,  burning face
This spontaneous case was reported by a non-health professional and describes the occurrence of PYREXIA (Fever) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine) in a 21-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 037C21A and 067C21A) for COVID-19 vaccination. No Medical History information was reported. On 28-Apr-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 30-Jun-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 30-Jun-2021, the patient experienced PYREXIA (Fever). On an unknown date, the patient experienced INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine). At the time of the report, PYREXIA (Fever) and INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION (Inappropriate schedule of vaccine) outcome was unknown. Concomitant product use was not provided by the reporter. Treatment information included Vicks NyQuil. Action taken with mRNA-1273 in response to the event was not applicable.
no adverse affects; extra dose administered; This spontaneous report was received from an administrator refers to a patient of unknown demographics. The patient's pertinent medical history, concomitant medications and drug reactions or allergies were not reported. On 27-AUG-2019, the patient was vaccinated with extra dose of varicella virus vaccine live (oka/merck)(VARIVAX) (strength, route of administration, anatomical location were unknown) of lot # R027995 and expiration date 01-OCT-2020 for prophylaxis (extra dose administered). No adverse effects reported. The outcome of extra dose administered was unknown. No product quality complaint reported.
Expired vaccine. No temperature excursions occurred. Moderna determined the vial "maintained the activity necessary to  protect against SARS Co-V2 virus at the time of administration." Patient reported no adverse reaction.
IHB 7550: see below: rash, chest pain, SOB after SPV.  Final dx viral exantham and anxiety.
Symptoms started with fast onset of leg cramping, painfull tingling like sharp needles in hands and hard to move as being awakened at about four in the morning.  Syamptoms lasted for about 2 hours as I was able to get up with some dizzyness later.
SORENESS; TIRED; This spontaneous report received from a patient concerned a male of unspecified age. The patient's weight, height, and medical history were not reported. On 16-MAR-2021, the patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: 1805031, and expiry date : 26-MAY-2021) dose was not reported, vaccinated on right deltoid, once a total administered on 17-MAR-2021 for prophylactic vaccination. No concomitant medications were reported. On 18-MAR-2021, the patient experienced tired, soreness. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from tired, and soreness on 19-MAR-2021. This report was non-serious.
Chest pressure 3 days after vaccine, turning into chest pain by day 5. Heart rate higher than normal. Sharp chest pains. 5 weeks after with issues continuing
Had a blood transfusion about a month ago; This spontaneous case was reported by a pharmacist and describes the occurrence of TRANSFUSION (Had a blood transfusion about a month ago) in a 90-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 007C21A and 027A21A) for COVID-19 vaccination.     No Medical History information was reported.   On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced TRANSFUSION (Had a blood transfusion about a month ago). At the time of the report, TRANSFUSION (Had a blood transfusion about a month ago) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No Concomitant medications were reported. No Treatment information was reported.
Fever over 100.5 for 50 hrs, over 101.5 for 12 hrs. Fatigue, nausea, anorexia, severe muscle aches. Painful, Swollen red arm appeared stung by bee.  Headache for three days
Large local reaction with erythema, swelling, firmness, inability to move arm that began 5 hours after injection. Spread to elbow and chest. Responded to PO Benadryl.
Patient is a 34 y.o. female who was seen at COVID Vaccine Clinic today for her first dose of the COVID 19 vaccination.    She denied any history of previous adverse reactions to vaccines.   She was given the Moderna vaccination in the right deltoid muscle.   During her 15 minute waiting period after the injection, the patient began to experience dizziness and diaphoresis.  She denied difficulty breathing, throat tightness and facial swelling.   This provider was notified of patient reaction and she was then assessed in the emergency bay area.   Monitored patient for severe reaction symptoms, including but not limited to blood pressure abnormality , rapid progression of symptoms and syncope. Patient states she last ate an apple with PB around 1pm today, but has not had much else today. Denies drinking much water today. She was working in surgery a majority of the day.
Mom called at 10:30 am c/o child had stomach cramps first 2 days with diarrhea since Saturday. Cramps stopped post BRAT diet Saturday. Advised electrolyte replacement and assess if continues. CAC on stool and urine and # of stools per day. See PMD.
RECEIVED 1ST DOSE OF PFIZER COVID 19 VACCINE ON 02/13/21. ON 02/22/21 WENT TO PROVIDER WITH COMPLAINT OF SEVERE HEADACHE AND WAS INSTRUCTED TO GO TO ER. ON 02/22/21 WENT TO ER WITH COMPLAINT OF SEVERE HEADACHE. DISCHARGE TO HOME SELF CARE IN REGARD TO FOLLOW UP WITH PCP FOR FURTHER EVALUATION SINCE DID NOT AGREE TO CT SCAN.
Patient said she has fever of 101'F, Arm swollen (orange size), NV.
Patient had localized redness, sore and hot to the touch, and a bump under the skin at injection site - occurred the day after injection.
First vaccine on April 26th.  Few days later, I developed coughs without any other symptoms.   Second one on May 28th, I had second dose since I do not have other symptoms no fever no sickness, besides dry coughs. I still have the same coughs. It is mild dry coughs without any pain.
Information has been received from a male consumer concerning his 13 month old female granddaughter with no known allergies who on approximately 5/1/02 was vaccinated with a dose of MMR (second generation). There was no concomitant medication. Ten days after receiving the vaccination, on approximately 5/11/02, the patient broke out in a fever, had loss of appetite, her lymph nodes were swollen, and she had a rash all over. It was reported that she also experienced some vomiting. The physician that was treating the patient believed that the patient had developed measles, mumps and rubella as a reaction to the MMR (second generation) shot. It was noted that the patient was hospitalized. The physician felt that the measles, mumps and rubella were related to the therapy with MMR (second generation). Additional information has been requested.
pt recvd vax 1SEP95 & 23SEP95 pt devel red spots which looked like a hive, but no pustules;reported that spots were itchy & there were a total of 10-15 all above the waistline;f/u from MD indicated that pt was unaware of any adverse rxn
Fever 102 no injection site cellulitis, myalgia arm on injection, neck shoulder left, sore throat, headache, weakness, near syncope, dyspnea.
Some pain with injection then approximately 2 days later extreme pain, muscle weakness and loss of range of motion having to limit activities.  Ibuprofen taken with mild relief.  Continues to have pain and muscle weakness on 3/28/08.  Pain wakes him up at night.
Information has been received from a physician concerning a 16 year old female with asthma who in December 2006, was vaccinated with the first dose of Gardasil. Concomitant therapy included FLOVENT, albuterol and ZYRTEC. In December 2006, a few hours following vaccination with Gardasil, the patient experienced itchiness and redness of her face. The patient sought unspecified medical attention. Subsequently on an unspecified date, the patient recovered from itchiness and redness of her face. Additional information has been requested.
This spontaneous report as received from a pharmacist refers to a 44 (now was 54 year old as reported) years old patient. The patient started therapy with an unspecified pneumococcal vaccine, polyvalent (23-valent) (manufacturer unknown) on an unspecified date 10 years ago and later developed pneumonia (date also unspecified). No concomitant medications were reported. It did not report the patient if sought medical attention. No treatment information was reported. The outcome of pneumonia was unknown. Follow-up information received reported that the 44 years old (at the time she received the vaccinated) did not know the manufacturer or trade name of the pneumococcal vaccine, polyvalent (23-valent) she received. Additional information is not expected.
This spontaneous report as received from a physician refers to a 62 year old female patient. The patient's concurrent conditions included dementia Alzheimer's type, aphasia, anxiety, libido decreased, depression, micturition urgency, cough and seasonal allergy. The patient's medical history included biopsy thyroid gland and colloid brain cyst. The patient was enrolled in the clinical trial (captured in MARRS # 1608USA014647). On 15-AUG-2016, the patient was vaccinated with zoster vaccine live (manufacturer unknown) (dose, route, lot # and expiration date were not reported). Concomitant therapies included montelukast (manufacturer unknown) and IOPHEN C NR. On 16-AUG-2016 (reported as the following morning), she developed a high fever, low blood pressure and muscle weakness and was brought into the hospital, the events were considered to be severe shingles vaccine adverse reaction. The patient was treated for fever, hypotension and generalized muscle weakness. She was tested for tick born infections (results unspecified) and was given intravenous (IV) fluids overnight. The patient felt at baseline following one overnight in the hospital. Her vital signs were stable. She was instructed to follow up with her primary care physician within one week of discharge. On 17-AUG-2016, the patient recovered from the events. The reporter considered pyrexia, muscular weakness and hypotension to be related to Zoster Vaccine Live (manufacturer unknown). Additional information has been requested.
first Shingrix 11/2019, hasn't gotten second; flu like symptoms; malaise; This case was reported by a consumer via call center representative and described the occurrence of influenza-like symptoms in a 70-year-old male patient who received Herpes zoster (Shingrix) for prophylaxis.   Co-suspect products included Herpes zoster (Shingrix) for prophylaxis.   In November 2019, the patient received the 1st dose of Shingrix (intramuscular) .5 ml. On an unknown date, the patient received the 2nd dose of Shingrix. On an unknown date, 12 hrs after receiving Shingrix and not applicable after receiving Shingrix, the patient experienced influenza-like symptoms, general malaise and incomplete course of vaccination. On an unknown date, the outcome of the influenza-like symptoms and general malaise were recovered/resolved and the outcome of the incomplete course of vaccination was unknown.   It was unknown if the reporter considered the influenza-like symptoms and general malaise to be related to Shingrix.  Additional details reported were as follows: This case was reported by the patient. The age at vaccination was not applicable for 2nd dose. About 12 hours of receiving Shingrix, the patient experienced flu like symptoms and general malaise.  These symptoms lasted for about 2 days Till the time of reporting the patient did not receive 2nd dose of Shingrix, which led to incomplete course of vaccination. The patient wanted to know how to proceed if he had not gotten his second yet but planned on doing so.  The patient referred to healthcare professional. The reporter did not consent to follow up. No health care professional for follow up.
Bruises on my right leg. Possible blood clot. Right leg has noticeable pain when bending and feels heavier/ different compared to my left leg.
Arm (at injection site) started swelling and became hot, warm to touch, and hard as rock with intense pain. Next day had fever, chills, extreme weakness/fatigue, loss of appetite, and generalized pain throughout body.  It has now been 6 days and still have a huge hard mass in arm.
Patient had already taken 2 doses of the pfizer in March 2021. She said that her physician told her to get the Janssen vaccine
After the vaccine a day and a half later I noticed my arm was itching and there was redness down my arm.  My arm near the injection site felt a little swollen too.
CLIENT RETURNED TO CLINIC FOR SKIN TEST READING AND SHOWED PHN SITE OF VARICELLA VACCINATION.  80X60 MM AREA OF ERYTHEMA AND SWELLING. VACCINE GIVEN 7/21/09, OFFICE VISIT 7/23/09.
Systemic: Chest Tightness / Heaviness / Pain-Medium, Systemic: Lymph Node Swelling-Medium, Systemic: Tachycardia-Mild, Additional Details: pt mom called 4 days post vaccination. i recommended going to urgent care or er. she said chest and armpit swollen with pain and pt thought heart was beating faster than normal.
This spontaneous case reported by a consumer, describes the occurrence of toothache (pain inside jaw and mouth like a toothache/pain in lower teeth) and lymphadenopathy (she also has swelling in lymph nodes in her throat) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine) for COVID-19 immunization. No medical history reported. On Jan 27, 2021, patient received the second dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On Jan 27, 2021, patient experienced toothache (pain inside jaw and mouth like a toothache/pain in lower teeth) and lymphadenopathy (she also has swelling in lymph nodes in her throat). At the time of the report, toothache (pain inside jaw and mouth like a toothache/pain in lower teeth) and lymphadenopathy (she also has swelling in lymph nodes in her throat) outcome: unknown. Treatment information and concomitant medications not provided.
Shot at 4 PM Monday.  Woke up at 3:30 AM Tuesday feeling very hot and thirsty.  Passed out in doorway of parents room when looking for assistance,  Came to and began to vomit.  Vomited several times.  Passed out a second time.  Ambulance called.  Hot, sweaty.  Fever and chills, massive headache and generally uncomfortable all day Tuesday.  Woke up Wednesday morning feeling 100% fine.
pt recv vax 2AUG96 & 29 days later mom noted 3 chickenpox like areas on pt trunk that later scabbed over; 14 days later a younger sibling started to break out w/chickenpox type rash & sl irritability;
pt reported no previous hx of Guillian-Barre synd (GBS). , he was very anxious and tense when receiving the vaccine, after the shot he reported a tingling sensation in his legs,  I discussed with the pt that this tingling sensation was most likely his body relaxing after tye shot, however in rare situations tingling is the 1st presenting sx of GBS and I recommended he be evaluated by a medical provider